Axon Enterprise
AXON
#539
Rank
A$65.74 B
Marketcap
A$833.18
Share price
0.24%
Change (1 day)
-17.02%
Change (1 year)

Axon Enterprise (AXON) - Total debt

Total debt on the balance sheet as of September 2025 : A$3.16 Billion

According to Axon Enterprise 's latest financial reports the company's total debt is A$3.16 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Axon Enterprise - Total debt on balance sheet (from 2001 to 2025)

Total debt by year

Year Total debt Change
2024-12-31A$1.16 B11.23%
2023-12-31A$1.04 B-0.18%
2022-12-31A$1.04 B3606.39%
2021-12-31A$28.19 M
2017-12-31A$0.05 M-67.92%
2016-12-31A$0.16 M47.23%
2015-12-31A$0.11 M35.82%
2014-12-31A$0.08 M-29.1%
2013-12-31A$0.11 M-12.41%
2012-12-31A$0.13 M
2011-12-31N/A
2007-12-31A$0.03 M-63.37%
2006-12-31A$0.09 M-40.72%
2005-12-31A$0.16 M2618.04%
2004-12-31A$0 M-98.34%
2003-12-31A$0.36 M-53.46%
2002-12-31A$0.77 M-69.93%
2001-12-31A$2.58 M-52.9%
2000-12-31A$5.48 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
XBiotech
XBIT
A$15.46 M-99.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
A$38.35 M-98.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$0.26 B-91.59%๐Ÿ‡บ๐Ÿ‡ธ USA